Age-Specific Causal Link for Adiposity, CV Risk Factors

This article originally appeared here.
Share this content:
Age-Specific Causal Link for Adiposity, CV Risk Factors
Age-Specific Causal Link for Adiposity, CV Risk Factors

TUESDAY, March 3, 2015 (HealthDay News) -- Adiposity has an age-specific causal effect on cardiovascular risk factors, according to research published online Feb. 23 in Diabetes.

Tove Fall, Ph.D., from Uppsala University in Sweden, and colleagues used a Mendelian randomization approach based on 32 genetic markers to examine the causal effect of adiposity on blood pressure, glycemic indices, circulating lipid levels, and markers of inflammation and liver disease. Data were included for 67,553 individuals. Analyses were stratified by age (cutoff, age, 55 years) and sex.

The researchers found that in both nonstratified and stratified analyses, the genetic score correlated with body mass index. In the nonstratified analysis and in the <55-year stratum, there was evidence of a causal effect of adiposity on blood pressure, fasting levels of insulin, C-reactive protein, interleukin-6, high-density lipoprotein cholesterol, and triglycerides. There was evidence of a smaller causal effect on total cholesterol in the ≥55 years stratum than in the <55-year stratum (P = 0.015).

"In conclusion, this study extends previous knowledge of the effects of adiposity by providing sex- and age-specific causal estimates on cardiovascular risk factors," the authors write.

Some of the studies which provided data reported funding from the pharmaceutical industry; one author disclosed financial ties to the Orion-Farmos Research Foundation.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »